Department of Microbiology and Immunology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.
Viruses. 2012 Apr;4(4):557-80. doi: 10.3390/v4040557. Epub 2012 Apr 12.
Coronavirus-cell entry programs involve virus-cell membrane fusions mediated by viral spike (S) proteins. Coronavirus S proteins acquire membrane fusion competence by receptor interactions, proteolysis, and acidification in endosomes. This review describes our current understanding of the S proteins, their interactions with and their responses to these entry triggers. We focus on receptors and proteases in prompting entry and highlight the type II transmembrane serine proteases (TTSPs) known to activate several virus fusion proteins. These and other proteases are essential cofactors permitting coronavirus infection, conceivably being in proximity to cell-surface receptors and thus poised to split entering spike proteins into the fragments that refold to mediate membrane fusion. The review concludes by noting how understanding of coronavirus entry informs antiviral therapies.
冠状病毒的细胞进入程序涉及病毒与细胞膜融合,由病毒穗状(S)蛋白介导。冠状病毒 S 蛋白通过与受体相互作用、蛋白水解和内体酸化获得膜融合能力。本综述描述了我们目前对 S 蛋白的理解,包括它们与这些进入触发物的相互作用和反应。我们专注于促使进入的受体和蛋白酶,并强调已知激活几种病毒融合蛋白的 II 型跨膜丝氨酸蛋白酶(TTSP)。这些和其他蛋白酶是允许冠状病毒感染的必需辅助因子,它们可能接近细胞表面受体,因此能够将进入的穗状蛋白分裂成重新折叠以介导膜融合的片段。该综述最后指出了对冠状病毒进入机制的理解如何为抗病毒治疗提供信息。